Sarissa Capital Wins Proxy Contest Against Amarin by Huge Landslide
February 28 2023 - 10:39AM
Business Wire
Sarissa honored to have received 100 million
more votes than Amarin board
Sarissa Capital Management LP today issued the following
statement regarding Amarin Corporation plc (NASDAQ: AMRN):
Amarin shareholders have sent a loud and clear message
repudiating the incumbent Amarin board. Sarissa thanks fellow
shareholders for their support in a resounding victory against the
Amarin board. Our estimate is that up to nearly 80% of shareholder
votes were in support of Sarissa. As Amarin’s largest shareholder,
we are grateful for the opportunity to remake Amarin for the
benefit of all shareholders.
Vascepa, the foundation on which Amarin is built, is a
tremendous drug that is compelling for patients and payors – a
unique proposition for a drug. While there is a lot of work to be
done, we remain confident in our ability to leverage Vascepa’s rare
and highly beneficial profile to unlock tremendous value for all
shareholders.
LET’S GET TO WORK AND FINALLY BEGIN
RUNNING AMARIN FOR THE BENEFIT OF ALL SHAREHOLDERS!
Additional Information
Sarissa Capital Management LP (“Sarissa Capital”), together with
other participants, filed a definitive proxy statement and an
accompanying blue proxy card with the SEC on January 31, 2023, in
connection with the solicitation of shareholders of Amarin
Corporation plc (the “Company”) at the general meeting of the
Company for the election of Sarissa Capital’s slate of
highly-qualified nominees (the “General Meeting”). Shareholders are
advised to read the definitive proxy statement and other relevant
documents related to the General Meeting as they contain important
information.
The definitive proxy statement and other relevant documents are
available at no charge on the SEC’s website at www.sec.gov and at
www.freeamarin.com. The definitive proxy statement and other
relevant documents are also available at no charge by directing a
request to Sarissa Capital’s proxy solicitor, D.F. King & Co.,
Inc., 48 Wall Street, New York, New York 10005 (Shareholders can
call toll-free: (800) 331-7024).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230228005961/en/
Dayna Packes Sarissa Capital Management LP info@sarissacap.com
#FreeAmarin
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From May 2023 to Jun 2023
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Jun 2022 to Jun 2023